DOCSLIB.ORG

ENTWURF 30.6.2016 MINISTERIALVERORDNUNG 07.2016 Nr

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
ENTWURF 30.6.2016 MINISTERIALVERORDNUNG 07.2016 Nr 1. ------IND- 2016 0331 EE- DE- ------ 20160719 --- --- PROJET ENTWURF 30.6.2016 MINISTERIALVERORDNUNG 07.2016 Nr. Änderung der Verordnung Nr. 73 des Sozialministers „Bedingungen und Verfahren zum Umgang mit Suchtstoffen und psychoaktiven Substanzen für medizinische und wissenschaftliche Zwecke sowie zur diesbezüglichen Führung von Aufzeichnungen und Berichterstattung sowie Listen der Suchtstoffe und psychoaktiven Substanzen“ vom 18. Mai 2005 Die Verordnung tritt auf Grundlage von § 3¹ Absatz 1 und § 4 Absatz 15 des Gesetzes über Suchtstoffe und psychoaktive Substanzen sowie deren Grundstoffe in Kraft. Anhang 1 der Verordnung Nr. 73 des Sozialministers „Bedingungen und Verfahren zum Umgang mit Suchtstoffen und psychoaktiven Substanzen für medizinische und wissenschaftliche Zwecke sowie zur diesbezüglichen Führung von Aufzeichnungen und Berichterstattung sowie Listen der Suchtstoffe und psychoaktiven Substanzen“ vom 18. Mai 2005 wird durch den Anhang der vorliegenden Verordnung ersetzt. Jevgeni Ossinovski Minister für Gesundheit und Arbeit Marika Priske Kanzlerin Anhang. Listen I-VI der Suchtstoffe, Suchtstoffgruppen und psychoaktiven Substanzen und Substanzgruppen Verordnung Nr. ... des Ministers für Gesundheit und Arbeit vom Juli 2016 „Änderung der Verordnung Nr. 73 des Sozialministers „Bedingungen und Verfahren zum Umgang mit Suchtstoffen und psychoaktiven Substanzen für medizinische und wissenschaftliche Zwecke sowie zur diesbezüglichen Führung von Aufzeichnungen und Berichterstattung sowie Listen der Suchtstoffe und psychoaktiven Substanzen“ vom 18. Mai 2005 sowie der Verordnung Nr. 30 des Sozialministers „Bedingungen und Verfahren zur Verschreibung und zur Aushändigung von Arzneimitteln in Apotheken sowie das Rezeptformular“ vom 8. Februar 2005“ Anhang 1 der Verordnung Nr. 73 des Sozialministers „Bedingungen und Verfahren zum Umgang mit Suchtstoffen und psychoaktiven Substanzen für medizinische und wissenschaftliche Zwecke sowie zur diesbezüglichen Führung von Aufzeichnungen und Berichterstattung sowie Listen der Suchtstoffe und psychoaktiven Substanzen“ vom 18. Mai 2005 LISTEN I-VI DER SUCHTSTOFFE, SUCHTSTOFFGRUPPEN UND PSYCHOAKTIVEN SUBSTANZEN UND SUBSTANZGRUPPEN LISTE I AB-CHMINACA; N-[(1S)-1-(Aminocarbonyl)-2- AB-CHMINACA; N-[(1S)-1-(aminocarbonyl)-2- methylpropyl]-1-(cyclohexylmethyl)-1H-indazol-3- methylpropyl]-1-(cyclohexylmethyl)-1H- carboxamid indazole-3-carboxamide AB-FUBINACA; N-(1-Amino-3-methyl-1- AB-FUBINACA; N-(1-amino-3-methyl-1- oxobutan-2-yl)-1-(4-fluorbenzyl)-1H-indazol-3- oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole- carboxamid 3-carboxamide AB-PINACA; N-(1-Amino-3-methyl-1-oxobutan-2- AB-PINACA; N-(1-amino-3-methyl-1-oxobutan- yl)-1-pentyl-1H-indazol-3-carboxamid 2-yl)-1-pentyl-1H-indazole-3-carboxamide ADB-CHMINACA; N-[1-(Aminocarbonyl)-2,2- ADB-CHMINACA; N-[1-(aminocarbonyl)-2,2- dimethylpropyl]-1-(cyclohexylmethyl)-1H-indazol- dimethylpropyl]-1-(cyclohexylmethyl)-1H- 3-carboxamid indazole-3-carboxamide ADB-FUBINACA; N-[(1S)-1-(Aminocarbonyl)-2,2- ADB-FUBINACA; N-[(1S)-1-(aminocarbonyl)- dimethylpropyl]-1-[(4-fluorphenyl)methyl]-1H- 2,2-dimethylpropyl]-1-[(4-fluorophenyl)methyl]- indazol-3-carboxamid 1H-indazole-3-carboxamide ADB-PINACA; N-(1-Amino-3,3-dimethyl-1- ADB-PINACA; N-(1-amino-3,3-dimethyl-1- oxobutan-2-yl)-1-pentyl-1H-indazol-3-carboxamid oxobutan-2-yl)-1-pentyl-1H-indazole-3- carboxamide AM-2201; 1-[(5-Fluorpentyl)-1H-indol-3-yl]- AM-2201; 1-[(5-fluoropentyl)-1H-indol-3-yl]- (naphthalen-1-yl)methanon (naphthalen-1-yl)methanone 2-Aminoindan (2-AI); 2,3-Dihydro-1H-inden-2- 2-aminoindane (2-AI); 2,3-dihydro-1H-inden-2- amin amine Amphetamin Amfetamine (amphetamine); (+–)-alfa- methylphenethylamine Amineptin Amineptine; (7-[(10,11-dihydro-5H- dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid) 2-Amino-1-(4-brom-2,5-dimethoxyphenyl)ethan- 2-amino-1-(4-bromo-2,5- 1-on (bk-2C-B) dimethoxyphenyl)ethan-1-one (bk-2C-B) 6-(2-Aminopropyl)benzofuran (6-APB) 6-(2-aminopropyl)benzofuran (6-APB) 5-(2-Aminopropyl)indol (5-API, 5-IT) 5-(2-aminopropyl)indole (5-API, 5-IT) APINACA; AKB48; 1-Pentyl-N- APINACA, AKB48; 1-pentyl-N- tricyclo[3.3.1.13,7]dec-1-yl-1H-indazol-3- tricyclo[3.3.1.13,7]dec-1-yl-1H-indazole-3- carboxamid carboxamide 4-Acetoxy-N,N-dimethyltryptamin (4-AcO-DMT; 4- 4-acetoxy-N,N-dimethyltryptamine (4-AcO- Acetoxy-DMT); O-Acetylpsilocin; Psilacetin; 3-[2- DMT; 4-acetoxy-DMT); O-acetylpsilocin; (Dimethylamino)ethyl]-1H-indol-4-ylacetat psilacetin; 3-[2-(dimethylamino)ethyl]-1H-indol- 4-yl acetate Acetylfentanyl; N-(1-Phenethyl-piperidin-4-yl)-N- Acetylfentanyl; N-(1-phenethylpiperidin-4-yl)-N- phenylacetamid phenylacetamide 1-(1-Benzofuran-5-yl)-N-ethylpropan-2-amin (5- 1-(1-benzofuran-5-yl)-N-ethylpropan-2-amine EAPB) (5-EAPB) 1-(Benzofuran-5-yl)-N-methylpropan-2-amin (5- 1-(benzofuran-5-yl)-N-methylpropan-2-amine MAPB) (5-MAPB) Benzylpiperazin (BZP) Benzylpiperazine (BZP) 1-(4-Brom-2,5-methoxyphenyl)-2-aminoethan 1-(4-bromo-2,5-dimethoxyphenethylamine; (2C-B; Nexus; BDMPEA) (2C-B; Nexus; BDMPEA) 2-(4-Brom-2,5-dimethoxyphenyl)-N-[(2- 2-(4-bromo-2,5-dimethoxyphenyl)-N-[(2- methoxyphenyl)methyl]ethanamin (25B-NBOMe; methoxyphenyl)methyl]ethanamine (25B- 2C-B-NBOMe; NBOMe-2C-B) NBOMe; 2C-B-NBOMe; NBOMe-2C-B) Brolamphetamin (DOB) Brolamfetamine (DOB); (+–)-4-bromo-2,5- dimethoxy-alfa-methylphenethylamine Buphedron (MABP); α- Buphedrone (MABP); α-methylamino- Methylaminobutyrophenon; 2-(methylamino)-1- butyrophenone; 2-(methylamino)-1- phenylbutan-1-on phenylbutan-1-one Butylon (bk-MBDB); 1-(1,3-Benzodioxol-5-yl)-2- Butylone (bk-MBDB); 1-(1,3-benzodioxol-5-yl)- (methylamino)butan-1-on 2-(methylamino)butan-1-one CP 47497; 5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3- CP 47497; 5-(1,1-dimethylheptyl)-2-[(1R,3S)-3- Hydroxycyclohexyl]phenol hydroxycyclohexyl]phenol CP 47497-C6-Homolog; 5-(1,1-Dimethylhexyl)-2- CP 47497-C6-homologe; 5-(1,1- [(1R,3S)-3-Hydroxycyclohexyl]phenol dimethylhexyl)-2-[(1R,3S)-3- hydroxycyclohexyl]phenol CP 47497-C8-Homolog; 5-(1,1-Dimethyloktyl)-2- CP 47497-C8-homologe; 5-(1,1-dimethyloctyl)- [(1R,3S)-3-Hydroxycyclohexyl]phenol 2-[(1R,3S)-3-hydroxycyclohexyl]phenol CP 47497-C9-Homolog; 5-(1,1-Dimethylnonyl)-2- CP 47497-C9-homologe; 5-(1,1- [(1R,3S)-3-Hydroxycyclohexyl]phenol dimethylnonyl)-2-[(1R,3S)-3- hydroxycyclohexyl]phenol Dexamphetamin Dexamfetamine (dexamphetamine); (+)-alfa- methylphenethylamine Deschloretizolam (ETZ-2); 2-Ethyl-9-methyl-4- Deschloroetizolam (ETZ-2); 2-ethyl-9-methyl-4- phenyl-6H-tieno[3,2-f][1,2,4]triazolo[4,3- phenyl-6H-tieno[3,2-f][1,2,4]triazolo[4,3- a][1,4]diazepin; Etizolam-2 a][1,4]diazepin; etizolam-2 Desoxypipradrol (2-DPMP); 2- Desoxypipradrol (2-DPMP); 2- (Diphenylmethyl)piperidin; 2-Benzhydrylpiperidin; (diphenylmethyl)piperidine; 2- Deoxypipradrol benzhydrylpiperidine; deoxypipradrol Diethyltryptamin (DET) Diethyltryptamine (DET); 3-[2- (diethylamino)ethyl]indole Diphenidin; 1-(1,2-Diphenylethyl)piperidin Diphenidine; 1-(1,2-diphenylethyl)piperidine Diclazepam (Chlordiazepam); 7-Chlor-5-(2- Diclazepam (chlorodiazepam); 7-chloro-5-(2- chlorphenyl)-1-methyl-1,3-dihydro-2H-1,4- chlorophenyl)-1-methyl-1,3-dihydro-2H-1,4- benzodiazepin-2-on benzodiazepin-2-one 3,4-Dichlor-N-[(1- 3,4-dichloro-N-[(1- dimethylamino)cyclohexylmethyl]benzamid (AH- dimethylamino)cyclohexylmethyl]benzamide 7921) (AH-7921) 3,4-Dichlor-N-[2-(dimethylamino)cyclohexyl]-N- 3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]- methylbenzamid (U-47700) N-methylbenzamide (U-47700) Dimethoxyamphetamin (DMA) Dimethoxyamfetamine (DMA); (+–)-2,5- dimethoxy-alfa-methylphenethylamine Dimethoxyphenylamphetamin (DOET) DOET; 4-ethyl-2,5-dimethoxy-alfa-methyl- phenethylamine 2,5-Dimethoxy-4-ethylphenethylamin (2C-E); 1- 2,5-dimethoxy-4-ethyl-phenethylamine (2C-E); (2,5-Dimethoxy-4-ethylphenyl)-2-aminoethan 1-(2,5-dimethoxy-4-ethylphenyl)-2- aminoethane 2,5-Dimethoxy-4-ethylthiophenethylamin (2C-T-2) 2,5 -dimethoxy-4-ethylthiophenethylamine (2C- T-2) 2,5-Dimethoxy-4-iodphenethylamin (2C-I) 2,5-dimethoxy-4-iodophenethylamine (2C-I) 2,5-Dimethoxy-4-chloramphetamin (DOC); 1-(4- 2,5-dimethoxy-4-chloroamphetamine (DOC); 1- chlor-2,5-dimethoxyphenyl)propan-2-amin (4-chloro-2,5-dimethoxyphenyl)propan-2-amine 2,5-Dimethoxy-4-propylphenethylamin (2C-P); 2- 2,5-dimethoxy-4-propylphenethylamine; (2C- (2,5-Dimethoxy-4-propylphenyl)ethanamin P); 2-(2,5-dimethoxy-4- propylphenyl)ethanamine 2,5-Dimethoxy-4-(n)-propylthiophenethylamin 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) (2C-T-7) Dimethyltryptamin (DMT) Dimethyltryptamine (DMT); 3-[2- (dimethylamino)ethyl]indole 4,4’-DMAR; Para-methyl-4 -methylaminorex; 4,4’- 4,4’-DMAR; para-methyl-4-methylaminorex; Dimethylaminorex 4,4’-dimethylaminorex DMHP DMHP; 3-(1,2-dimethylheptyl)-7,8,9,10- tetrahydro-6,6,9-trimethyl-6H- dibenzo[b,d]pyran-1-ol Kratom Mitragyna speciosa (Kratom) Esketamin* Esketamine* Etizolam; 4-(2-Chlorphenyl)-2-ethyl-9-methyl-6H- Etizolam; 4-(2-chlorophenyl)-2-ethyl-9-methyl- thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin 6H-thieno[3,2-f][1,2,4]¬triazolo[4,3- a][1,4]diazepine Eticyclidin (PCE) Eticyclidine (PCE); N-ethyl-1- phenylcyclohexylamine Etryptamin Etryptamine Ethylon (bk-MDEA; MDEC); 2-Ethylamino-1-(3,4- Ethylone (bk-MDEA; MDEC); 2-ethylamino-1- methylendioxyphenyl)propan-1-on (3,4-methylenedioxyphenyl)propan-1-one Ethylphenidat (EP); Ethyl-2-phenyl-2-(piperidin-2- Ethylphenidate (EP); ethyl-2-phenyl-2- yl)acetat (piperidin-2-yl)acetate 5F-AKB48 (AKB-48F; 5-Fluor-AKB-48); N-(1- 5F-AKB48 (AKB-48F; 5-Fluoro-AKB-48); N-(1- Adamantyl)-1-(5-fluorpentyl)-1H-indazol-3- adamantyl)-1-(5-fluoropentyl)-1H-indazole-3- carboxamid carboxamide
Load more

Recommended publications
  • N.A.B 33,The Narcotic Drugs and Psychotropic Substances Bill For
    THE NARCOTIC DRUGS AND PSYCHOTROPIC SUBSTANCES BILL, 2021 MEMORANDUM The objects of this Bill are to— (a) provide for the functions of the Drug Enforcement Commission; (b) revise and consolidate the law relating to drugs and precursor chemicals; (c) provide for special measures relating to the prevention, treatment and rehabilitation of victims of drug abuse; (d) repeal and replace the Narcotic Drugs and Psychotropic Substances Act, 1993; (e) domesticate the Convention on Psychotropic Substances 1971, the United Nations Convention against Illicit Traffic in Nacortic Drugs and Psychotropic Substances, 1998 and the United Nations Convention against Transnational Organised Crime, 2003; and (f) provide for matters connected with, or incidental to, the foregoing L. KALALUKA, Attorney-General N.A.B. 33, 2021 14th April, 2021 Narcotic Drugs and Psychotropic [No. of 2021 3 Substances THE NARCOTIC DRUGS AND PSYCHOTROPIC SUBSTANCES BILL, 2021 ARRANGEMENT OF SECTIONS PART I PRELIMINARY PROVISIONS Section 1. Short title and commencement 2. Interpretation PART II THE DRUG ENFORCEMENT COMMISSION 3. Establishment of the Drug Enforcement Commission 4. Functions of Commission 5. Constitution of Staff Board 6. Functions of Staff Board 7. Director-General 8. Powers of Director-General 9. Deputy Director-General 10. Investigating officers and other staff 11. Identity card 12. Oath on appointment 13. Guidance by Commission 14. Report and recommendations by Commission PART III OFFENCES AND PENALTIES 15. Prohibition of trafficking in drug or precursor chemical 16. Prohibition of import or export of drugs or precursor chemical 17. Prohibition of trade in drug or precursor chemical 18. Prohibition of possession of drug or precursor chemical 19.
    [Show full text]
  • Medicines and Related Substances Act No. 101 of 1965
    MEDICINES AND RELATED SUBSTANCES ACT NO. 101 OF 1965 [View Regulation] [ASSENTED TO 19 JUNE, 1965] [DATE OF COMMENCEMENT: 1 APRIL, 1966] (Afrikaans text signed by the State President) This Act was published in Government Gazette 40869 dated 26 May, 2017. as amended by Drugs Control Amendment Act, No. 29 of 1968 Drugs Control Amendment Act, No. 88 of 1970 Drugs Laws Amendment Act, No. 95 of 1971 Drugs Control Amendment Act, No. 65 of 1974 Medicines and Related Substances Control Amendment Act, No. 19 of 1976 Health Laws Amendment Act, No. 36 of 1977 Medicines and Related Substances Control Amendment Act, No. 17 of 1979 Medicines and Related Substances Control Amendment Act, No. 20 of 1981 Transfer of Powers and Duties of the State President Act, No. 97 of 1986 [with effect from 3 October, 1986] Businesses Act, No. 71 of 1991 [with effect from 24 May, 1991] Medicines and Related Substances Control Amendment Act, No. 94 of 1991 General Law Amendment Act, No. 49 of 1996 [with effect from 4 October, 1996] Abolition of Restrictions on the Jurisdiction of Courts Act, No. 88 of 1996 [with effect from 22 November, 1996] Medicines and Related Substances Control Amendment Act, No. 90 of 1997 Medicines and Related Substances Amendment Act, No. 59 of 2002 Judicial Matters Amendment Act, No. 66 of 2008 [with effect from 17 February, 2009] Medicines and Related Substances Amendment Act No. 72 of 2008 Medicines and Related Substances Amendment Act, No. 14 of 2015 GENERAL NOTE There is a discrepancy between the English and Afrikaans texts of section 1 of Act No.
    [Show full text]
  • WO 2014/085719 Al 5 June 2014 (05.06.2014) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2014/085719 Al 5 June 2014 (05.06.2014) P O P C T (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every A61M 15/00 (2006.01) A24F 47/00 (2006.01) kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, (21) International Application Number: BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, PCT/US20 13/072426 DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (22) International Filing Date: HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, 27 November 2013 (27.1 1.2013) KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, (25) Filing Language: English OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, (26) Publication Language: English SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, (30) Priority Data: ZW. 61/730,738 28 November 2012 (28. 11.2012) US 61/794,601 15 March 2013 (15.03.2013) US (84) Designated States (unless otherwise indicated, for every 61/83 1,992 6 June 2013 (06.06.2013) us kind of regional protection available): ARIPO (BW, GH, 61/887,045 4 October 201 3 (04.
    [Show full text]
  • Lamy, F., Daniulaityte, R., Barratt, M., Lokala, U., Sheth, A., & Carlson, R
    This is the peer reviewed version of the following article: Lamy, F., Daniulaityte, R., Barratt, M., Lokala, U., Sheth, A., & Carlson, R. (2020). Listed for sale: Analyzing data on fentanyl, fentanyl analogs and other novel synthetic opioids on one cryptomarket. Drug and Alcohol Dependence, 213, 108115. which has been published in final form at https://doi.org/10.1016/j.drugalcdep.2020.108115 This article may be used for non-commercial purposes in accordance with Elsevier’s Article Sharing policy and Hosting policy © 2020. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/ Journal Pre-proof Listed for sale: analyzing data on fentanyl, fentanyl analogs and other novel synthetic opioids on one cryptomarket Francois R. Lamy, Raminta Daniulaityte, Monica J. Barratt, Usha Lokala, Amit Sheth, Robert G. Carlson PII: S0376-8716(20)30280-5 DOI: https://doi.org/10.1016/j.drugalcdep.2020.108115 Reference: DAD 108115 To appear in: Drug and Alcohol Dependence Received Date: 12 February 2020 Revised Date: 14 May 2020 Accepted Date: 8 June 2020 Please cite this article as: Lamy FR, Daniulaityte R, Barratt MJ, Lokala U, Sheth A, Carlson RG, Listed for sale: analyzing data on fentanyl, fentanyl analogs and other novel synthetic opioids on one cryptomarket, Drug and Alcohol Dependence (2020), doi: https://doi.org/10.1016/j.drugalcdep.2020.108115 This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record.
    [Show full text]
  • Customs (Prohibited Exports) Regulations 1958
    Customs (Prohibited Exports) Regulations 1958 Statutory Rules 1958 No. 5 as amended made under the Customs Act 1901 This compilation was prepared on 20 February 2007 taking into account amendments up to SLI 2007 No. 4 [Note: Regulation 7 ceases to have effect at the end of 31 July 2007 and Regulation 9 in Table A ceases to have effect either at the end of 31 December 2007 or at a time the Security Council so declares] Prepared by the Office of Legislative Drafting and Publishing, Attorney-General’s Department, Canberra Contents Page Contents Part 1 Preliminary 1 Name of Regulations [see Note 1] 6 2 Interpretation 6 Part 2 Exemptions 2A Exemption of goods specified in Schedule 3 9 Part 3 Prohibited exports Division 1 Miscellaneous prohibited exports 3 Exportation of objectionable goods 10 4 Exportation of goods mentioned in Schedule 1 (asbestos) 13 4A Exportation of goods mentioned in Schedule 2 (chemicals) 14 5 Exportation of goods specified in Schedule 3 (primary produce) 16 6 Exportation of goods specified in Schedule 4 (toothfish) 16 7 Exportation of human embryos 17 8 Exportation of goods specified in Schedule 6 (human substances) 22 9 Exportation of goods specified in Schedule 7 (nuclear material) 24 9AA Exportation of rough diamonds 27 9AB Exportation of cat and dog fur 28 9AC Exportation of security sensitive ammonium nitrate 30 9AD Exportation of goods specified in Schedule 7A (high activity radioactive sources) 31 Division 2 Drugs and precursor substances 9A Definitions for Division 2 33 10 Exportation of goods specified in Schedule
    [Show full text]
  • Customs (Prohibited Exports) Regulations 1958
    Customs (Prohibited Exports) Regulations 1958 Statutory Rules No. 5, 1958 made under the Customs Act 1901 Compilation No. 95 Compilation date: 30 March 2020 Includes amendments up to: F2020L00343 Registered: 20 April 2020 Prepared by the Office of Parliamentary Counsel, Canberra Authorised Version F2020C00301 registered 20/04/2020 About this compilation This compilation This is a compilation of the Customs (Prohibited Exports) Regulations 1958 that shows the text of the law as amended and in force on 30 March 2020 (the compilation date). The notes at the end of this compilation (the endnotes) include information about amending laws and the amendment history of provisions of the compiled law. Uncommenced amendments The effect of uncommenced amendments is not shown in the text of the compiled law. Any uncommenced amendments affecting the law are accessible on the Legislation Register (www.legislation.gov.au). The details of amendments made up to, but not commenced at, the compilation date are underlined in the endnotes. For more information on any uncommenced amendments, see the series page on the Legislation Register for the compiled law. Application, saving and transitional provisions for provisions and amendments If the operation of a provision or amendment of the compiled law is affected by an application, saving or transitional provision that is not included in this compilation, details are included in the endnotes. Editorial changes For more information about any editorial changes made in this compilation, see the endnotes. Modifications If the compiled law is modified by another law, the compiled law operates as modified but the modification does not amend the text of the law.
    [Show full text]
  • ENTWURF 6.3.2018 MINISTERIALVERORDNUNG Nr. Änderung
    1. ------IND- 2018 0134 EE- DE- ------ 20180416 --- --- PROJET ENTWURF 6.3.2018 SOZIALMINISTERIUM MINISTERIALVERORDNUNG Nr. Änderung der Verordnung Nr. 73 des Sozialministers „Bedingungen und Verfahren zum Umgang mit Suchtstoffen und psychoaktiven Substanzen für medizinische und wissenschaftliche Zwecke sowie zur diesbezüglichen Führung von Aufzeichnungen und Berichterstattung sowie Listen der Suchtstoffe und psychoaktiven Substanzen“ vom 18. Mai 2005 Die Verordnung tritt auf Grundlage von § 3¹ Absatz 1 des Gesetzes über Suchtstoffe und psychoaktive Substanzen sowie deren Grundstoffe in Kraft. Anhang 1 der Verordnung Nr. 73 des Sozialministers „Bedingungen und Verfahren zum Umgang mit Suchtstoffen und psychoaktiven Substanzen für medizinische und wissenschaftliche Zwecke sowie zur diesbezüglichen Führung von Aufzeichnungen und Berichterstattung sowie Listen der Suchtstoffe und psychoaktiven Substanzen“ vom 18. Mai 2005 wird durch den Anhang der vorliegenden Verordnung ersetzt. (digital unterzeichnet) Jevgeni Ossinovski (digital unterzeichnet) Minister für Gesundheit und Marika Priske Arbeit Kanzlerin Anhang. Listen I-VI der Suchtstoffe, Suchtstoffgruppen und psychoaktiven Substanzen und Substanzgruppen 2 Verordnung Nr. des Ministers für Gesundheit und Arbeit vom März 2018 „Änderung der Verordnung Nr. 73 des Sozialministers ‚Bedingungen und Verfahren zum Umgang mit Suchtstoffen und psychoaktiven Substanzen für medizinische und wissenschaftliche Zwecke sowie zur diesbezüglichen Führung von Aufzeichnungen und Berichterstattung sowie Listen
    [Show full text]
  • Connecticut Comprehensive Drug Laws
    Connecticut Comprehensive Drug Laws September 2011 Prepared by the DEPARTMENT OF CONSUMER PROTECTION Drug Control Division Commission of Pharmacy Dannel Malloy, GOVERNOR William Rubinstein, COMMISSIONER Table of Contents CHAPTER 400j PHARMACY Table of Contents Sec. 20‐570. Short title: Pharmacy Practice Act. Sec. 20‐571. (Formerly Sec. 20‐184a). Definitions. Sec. 20‐572. (Formerly Sec. 20‐163). Commission of Pharmacy. Appointment and term of members. Sec. 20‐573. (Formerly Sec. 20‐165). Meetings of commission. Records. Sec. 20‐574. (Formerly Sec. 20‐164a). General supervision by Commissioner of Consumer Protection. Sec. 20‐575. Powers and responsibilities. Sec. 20‐576. (Formerly Sec. 20‐164). Regulations. Sec. 20‐577. (Formerly Sec. 20‐179). Employment of inspectors by Commissioner of Consumer Protection; duties. Inspection of correctional, juvenile training and care‐giving institutions, dispensing outpatient facilities, institutional and retail pharmacies by commissioner. Sec. 20‐578. (Formerly Sec. 21a‐306). Information not to be disclosed. Exception. Sec. 20‐579. (Formerly Sec. 20‐175). Causes for suspension, revocation or refusal to issue or renew licenses, temporary permits and registrations and for assessment of civil penalty. Sec. 20‐580. (Formerly Sec. 20‐167). Revocation or suspension of nonlegend drug permit. Sec. 20‐581. (Formerly Sec. 20‐185). Penalty for violation of Pharmacy Practice Act. Exception. Sec. 20‐582. (Formerly Sec. 20‐176). Appeals of decisions of Commission of Pharmacy. Sec. 20‐583. Where appeals returnable. Secs. 20‐584 to 20‐589. Sec. 20‐590. (Formerly Sec. 20‐170). Issuance of license or temporary permit to practice pharmacy; requirements. Sec. 20‐591. Graduates of foreign pharmacy schools. Regulations.
    [Show full text]
  • Listed for Sale: Analyzing Data on Fentanyl, Fentanyl Analogs and Other Novel Synthetic Opioids on One Cryptomarket T
    Drug and Alcohol Dependence 213 (2020) 108115 Contents lists available at ScienceDirect Drug and Alcohol Dependence journal homepage: www.elsevier.com/locate/drugalcdep Full length article Listed for sale: Analyzing data on fentanyl, fentanyl analogs and other novel synthetic opioids on one cryptomarket T Francois R. Lamya,*, Raminta Daniulaityteb, Monica J. Barrattc,d, Usha Lokalae, Amit Shethf, Robert G. Carlsong a Department of Society and Health, Faculty of Social Sciences and Humanities, Mahidol University, Salaya, Thailand b College of Health Solutions, Arizona State University, Phoenix, AZ, United States c Social and Global Studies Centre, RMIT University, Melbourne, VIC, Australia d National Drug and Alcohol Research Centre, UNSW Sydney, NSW, Australia e Kno.e.sis Center, Department of Computer Science, Wright State University, Dayton, OH, United States f Artificial Intelligence Center, University of South Carolina, Columbia, SC, United States g Center for Interventions, Treatment, and Addictions Research, Department of Population and Public Health Sciences, Wright State University, Dayton, OH, United States ARTICLE INFO ABSTRACT Keywords: Background: The United States is facing a "triple wave" epidemic fueled by novel synthetic opioids. Cryptomarkets Cryptomarkets, anonymous marketplaces located on the deep web, play an increasingly important role in the Darknet markets distribution of illicit substances. This article presents the data collected and processed by the eDarkTrends Fentanyl platform concerning the availability trends
    [Show full text]
  • Department of Consumer Protection Designation of Controlled Drugs
    Regulations of Connecticut State Agencies TITLE 21a. Consumer Protection Agency Department of Consumer Protection Subject Designation of Controlled Drugs Inclusive Sections §§ 21a-243-1—21a-243-18 CONTENTS Sec. 21a-243-1. Volatile substances Sec. 21a-243-2. Criminal liability of vendor Sec. 21a-243-3. When volatile substances not controlled drug Sec. 21a-243-4. Anesthesia Sec. 21a-243-5. Controlled drugs Sec. 21a-243-6. Amyl nitrate Schedules of Controlled Substances Sec. 21a-243-7. Controlled substances in schedule I Sec. 21a-243-8. Controlled substances in schedule II Sec. 21a-243-9. Controlled substances in schedule III Sec. 21a-243-10. Controlled substances in schedule IV Sec. 21a-243-11. Controlled substances in schedule V Drug Prescriptions Transmitted by Facsimile Machines Sec. 21a-243-12. Definitions Sec. 21a-243-13. Dispensing of prescriptions transmitted by means of a facsimile machine Sec. 21a-243-14. Schedule II controlled substances Sec. 21a-243-15. Schedule III, IV and V controlled substances Sec. 21a-243-16. Accuracy of prescription Sec. 21a-243-17. Relationship with prescribing practitioners and health care facilities Sec. 21a-243-18. Control of prescription forms Revised: 2015-11-5 R.C.S.A. §§ 21a-243-1—21a-243-18 - I- Regulations of Connecticut State Agencies TITLE 21a. Consumer Protection Department of Consumer Protection §21a-243-3 Designation of Controlled Drugs Sec. 21a-243-1. Volatile substances (a) The following volatile substances are hereby designated as controlled drugs to the extent that said chemical substances
    [Show full text]
  • Republic of Vanuatu Customs Act No.7 of 2013
    REPUBLIC OF VANUATU CUSTOMS ACT NO.7 OF 2013 Customs (Prohibited Import) Regulations Order No. 115 Of2014 In exercise of the powers conferred on me by paragraphs 65(1)(a) and 215(2)(b) and section 216 ofthe Customs Act No.7 of2013, I, the Honourable MAKI SIMELUM, Minister of Finance and Economic Management, make the following Order. 1 Interpretation For the purposes of this Order, alcohol means pure alcohol or crude spirit of a strength not less than 68% by volume which has not been rendered unfit for human consumption and which can be used for making or distilling spirituous liquids; ammunition means ammunition for any firearm as defined in this section and includes grenades, bombs and other like missiles whether capable of use with firearms or not and also includes prohibited ammunition but does not include spears discharged from a firearm solely for the purpose of killing fish; explosive means gunpowder, blasting powder, dynamite, nitro-glycerine, gun­ cotton, fulminate of mercury and every other substance not specified, used with a view to produce an effect by explosion and includes detonators, fuse and every accessory composed of a detonating or inflammable substance used to produce explosions and includes crackers and rockets; Customs (Prohibited Import) Regulations Order No. nO" 0/2014 animal means any living stage of any member of the animal kingdom except human beings and includes arachnids, birds, crustaceans, fish, insects and reptiles and also any fertilised egg or ovum; animal product means any part of the animal including
    [Show full text]
  • Dangerous Drugs [CAP 143]
    LAWS OF THE REPUBLIC OF VANUATU Consolidated Edition 2006 DANGEROUS DRUGS [CAP. 12] Commencement: 1 December 1939 CHAPTER 12 DANGEROUS DRUGS JR 12 of 1939 JR 7 of 1952 JR 3 of 1959 JR 34 of 1975 Act 33 of 1984 Act 29 of 1989 Instrument of Variation pub. Gaz. 25 of 2005 ARRANGEMENT OF SECTIONS 1. Interpretation 10. Seizures 2. Prohibited substances and materials 11. Searches of the person 3. Exemptions 12. Search warrants 4. Prohibition of cultivation of cannabis plant 13. Obstruction to officers searching 5. Permitting premises to be used for smoking 14. Offence against conditions of permits cannabis 15. Evidence 6. Variation of listed drugs 16. Forfeiture of vessel etc., used for carrying drugs 7. Import certificate 17. Penalties for contravention of Act 8. Control of imports 18. Condemnation 9. Conditions of sale and supply by medical and veterinary practitioners and chemists SCHEDULE – Import certificate 1 LAWS OF THE REPUBLIC OF VANUATU Consolidated Edition 2006 DANGEROUS DRUGS [CAP. 12] DANGEROUS DRUGS To regulate the importation, sale, supply and possession of certain dangerous drugs in Vanuatu. 1. Interpretation In this Act unless the context otherwise requires – “Cannabis” (except in the expression "Cannabis resin") means any plant of the genus Cannabis or any part of any such plant (by whatever name designated) or the seeds of such plant except that it does not include Cannabis resin or any of the following products after separation from the rest of the plant, namely – (a) mature stalk of any such plant; (b) fibre produced from mature stalk of any such plant; “Cannabis resin” means the separated resin, whether crude or purified, obtained from any plant of the genus Cannabis.
    [Show full text]